It is important to add pain management to leprosy treatment protocols. This can reduce the challenges that patients face. Read on.

A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...

Federal officials on Thursday approved a new type of pain drug designed to eliminate the risks of addiction and overdose ...

The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction ...

The FDA has approved Journavx, a new non-opioid pain medication designed to reduce addiction and overdose risks.

Chronic pain affects approximately 1 in 5 Americans, and yet it remains one of the most misunderstood and challenging medical ...

After a long day — you want to take a load off. Yet, instead of kicking your feet up, try laying them on this highly-rated ...

The U.S. Food and Drug Administration (FDA) on Thursday approved Journavx, the first new class of pain medication in more ...

Despite advances, there remain gaps in the understanding of and personalized treatment for chronic pain in rheumatology, especially among women.

Acute and chronic postoperative pain and functional disability persisted among patients who underwent posterior spinal fusion despite multimodal analgesic management.

A novel biomarker signature combining PAF and CME predicts chronic pain risk, linking brain activity to individual pain ...